Intracerebroventricular infusion of CRF increases extracellular concentrations of norepinephrine in the hippocampus and cortex as determined by in vivo voltammetry
J. Zhang et al., Intracerebroventricular infusion of CRF increases extracellular concentrations of norepinephrine in the hippocampus and cortex as determined by in vivo voltammetry, BRAIN RES B, 47(3), 1998, pp. 277-284
Previous studies have indicated that intracerebroventricular (i.c.v.) infus
ions of corticotropin-releasing factor (CRF) activate locus coeruleus (LC)
noradrenergic neurons and increase the metabolism and extracellular concent
rations of norepinephrine (NE) in several brain regions, suggesting increas
ed release. To examine the temporal aspects and mechanism of the presumed r
elease of NE, CRF was infused i.c.v. and the oxidation current was recorded
using carbon fiber voltammetric electrodes placed in rat hippocampus or co
rtex. The CRF (1 mu g, i.c.v.) caused a significant increase of oxidation c
urrent with a delay of approximately 5 min, and a peak at approximately 35
min. Similar responses were observed in the medial prefrontal cortex, The h
ippocampal response was markedly attenuated when CRF was infused into rats
pretreated with DSP-4 to deplete NE, suggesting that the observed changes i
n current resulted from oxidation of NE, The increase of NE-like current di
d not occur when 25 mu g alpha-helical CRF9-41 (ah-CRF) was injected immedi
ately before 1 pg CRF, suggesting that the response was mediated by cerebra
l CRF-receptors. Subcutaneous pretreatment with the ganglionic blocker, chl
orison-damine, at a dose of 3 mg/kg had no effect on the voltammetric respo
nse to CRF, but a 6 mg/kg dose completely prevented the response, The P-adr
enoceptor antagonists, S-propranolol (5 mg/kg), nadolol (5 and 10 mg/kg), a
nd timolol (5 mg/kg) attenuated the NE response to i.c.v. CRF to varying de
grees. When chlorisondamine (3 mu g) or nadolol (5 mu g) were given i.c.v.
before the CRF, the hippocampal responses were not blocked, These results s
uggest peripheral actions of ganglionic and p-adrenergic blockers. We concl
ude that peripheral autonomic mechanisms, and probably both central and per
ipheral P-adrenoceptors, contribute to the increased secretion of hippocamp
al NE in response to i.c.v. CRF. (C) 1998 Elsevier Science Inc.